Back to ELDN
GOLDMAN SACHS GROUP INC → ELDN
GOLDMAN SACHS GROUP INC ELDN Position History
Eledon Pharmaceuticals, Inc. • Healthcare
Quarters held
13
Latest value
$203K
Q2 2026
Peak value
$7M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $73K |
| Q3 2025 | $111K |
| Q3 2025 | $47K |
| Q4 2025 | $96K |
| Q4 2025 | $204K |
| Q4 2025 | $204K |
| Q4 2025 | $96K |
| Q1 2026 | $385K |
| Q1 2026 | $709K |
| Q1 2026 | $46K |
| Q2 2026 | $2.7M |
| Q2 2026 | $7M |
| Q2 2026 | $203K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $203K | 51.4K | — | — |
| Q2 2026 | $7M | 1.77M | — | — |
| Q2 2026 | $2.7M | 686.2K | — | — |
| Q1 2026 | $46K | 14.8K | — | — |
| Q1 2026 | $709K | 230.3K | — | — |
| Q1 2026 | $385K | 125.0K | — | — |
| Q4 2025 | $96K | 63.4K | — | — |
| Q4 2025 | $204K | 135.3K | — | — |
| Q4 2025 | $204K | 135.3K | — | — |
| Q4 2025 | $96K | 63.4K | — | — |
| Q3 2025 | $47K | 18.2K | — | — |
| Q3 2025 | $111K | 42.8K | — | — |
| Q2 2025 | $73K | 26.9K | — | — |